Antibiotic prophylaxis for infective endocarditis

Clinical Microbiology and Infection

Volumn 4, Issue SUPPL. 3, 1998, Pages 3s56-3s61

  Leport, Catherine ^a   Al Halees, ^a   Daniel, W G ^a   Durack, D ^a   Francioli, P ^a   Gutschik, E ^a   Ngu Blackett, K ^a   Stamboulian, D ^a   Van Der Meer, J T M ^a   Wilson, W R ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLINDAMYCIN; GENTAMICIN; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; VANCOMYCIN;

BACTERIAL ENDOCARDITIS; COMPARATIVE STUDY; DENTAL SURGERY; GASTROINTESTINAL SURGERY; HEART DISEASE; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; UPPER RESPIRATORY TRACT; UROLOGIC SURGERY;

BACTERIA (MICROORGANISMS);

EID: 13144283648     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bayliss R, Clarke C, Oakley C, Somerville W, Whitfield AGW. The teeth and infective endocarditis, Br Heart J 1983; 50: 513-19.
2. Delahaye F, Goulet V, Lacassin F, et al. Characteristics of infective endocarditis in France in 1991 a one-year survey. Eur. Heart J 1995; 16: 394-401.
3. Van Der Meer J, Van Wijk W, Thompson J, Vanderbroucke J, Walkerburg H, Michel M. Efficacy of antibiotic prophylaxis for prevention of native valve endocarditis. Lancet. 1992; 339. 135-9.
4. Editorial. Chemoprophylaxis for infective endocarditis, faith, hope and charity challenged Lancet 1992; 339: 525-6.
5. Imperiale TE, Horwitz RI. Does prophylaxis prevent postdental IE? A controlled evaluation of protective efficacy. Am J Med 1990; 88; 131-6.
6. Lacassin F, Hoen B, Leport C, et al. Procedures associated with infective endocarditis in adults. A control study. Eur Heart J 1995; 16: 1968-74.
7. Empfehlungen der Schweizerishen Arbeitsgruppe fur endokarditisprophylaxe. Prophylaxe der bakteriellen endokarditis. Schweiz Med Wochenschr 1984; 114: 1246-52.
8. Empfehlungen zur Prophylaxe bakterieller Endokarditiden. Herausgegeben von der Kommission für Klinische Kardiologie der Deutschen Gesellschaft für Herz - und Kreislaufforschung. Z Kardiol 1987; 76: 451-3.
9. Working Party of the British Society for Antimicrobial Chemotherapy - The antibiotic prophylaxis of infective endocarditis. Lancet 1990; 335: 88-9.
10. Dajani AS, Bisno AL, Chung KJ, et al. Prevention of bacterial endocarditis Recommendations by the American Heart Association. JAMA 1990; 264. 2919-22.
11. Endocarditis prophylaxis in the Netherlands. Hartbulletin 1992; 23: 249-53.
12. Texte de Consensus. Prophylaxie de l'Endocardite Infectieuse. Med Mal Infect 1992: 22(special): 1119-41.
13. Glauser MP, Bernard JP, Moreillon P, Francioli P. Successful single dose amoxicillin prophylaxis against experimental endocarditis: evidence for two mechanisms of protection. J Infect Dis 1983; 145: 568-75.
14. Francioli P, Glauser P. Comparison of single doses of amoxicillin or of amoxicillin-gentamicin for the prevention of endocarditis caused by Streptococcus faecalis and by viridans streptoccoci. J Infect Dis 1985; 152(1): 83-9
15. Moreillon P, Overholser CD, Mahnverni R, Bille J, Glauser MP. Predictors of endocarditis in isolates from cultures of blood following dental extractions in rats with penodontal disease. J Infect Dis 1988; 157: 990-5.
16. Berney P, Francioli P. Successful prophylaxis of experimental streptococcal endocarditis with single-dose amoxicillin administered after bacterial challenge. J Infect Dis 1990; 161: 281-5.
17. Fluckiger V, Moreillon P, Blaser J, Bickle M, Glauser MP, Francioli P. Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcus endocarditis in rats. Antimicrob Agents Chemother 1994; 38: 2846-9.
18. Calderwood SB, Swinski LA, Waternaux CM, Karchmer AW, Buckley MJ. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985; 72(1): 31-7.
19. Horstkotte D, Fridrichs W, Pippert H, Bircks W, Loogen F. Nutzen der endokarditispropphylaxie bei patienten mit prosthetischen herklappen. Z Kardiol 1986; 75: 8-11.
20. Leport C, Vildé JL, Bricaire F, et al. Fifty cases of late prosthetic valve endocarditis: improvement in prognosis over a 15 year period. Br Heart J 1987, 58: 66-71.
21. Everett ED, Hirschmann JV. Transient bacteraemia and endocarditis prophylaxis: a review. Medicine 1977, 56: 61-77.
22. Sugrue D, Blake S, Troy P, McDonald D. Antibiotic prophylaxis against infective endocarditis after normal delivery - is it necessary? Br Heart J 1980; 44: 499-502.
23. Steckelberg JM, Khandheria BK, Anhalt JP, et al. Prospective evaluation of the risk of bacteremia associated with transoesophageal echocardiography. Circulation 1991; 84: 177-80.
24. Durack DT. Prevention of infective endocarditis. N Engl J Med 1995; 332: 38-43.
25. Simmons NA, Ball AP, Cawson RA, et al. Dental prophylaxis for endocarditis. Lancet 1992; 340: 1353.
26. Simmons NA. Recommendations for endocarditis prophylaxis. J Antimicrob Chemother 1993; 31: 437-8.
27. Gutschik E, Lippert S. Dental procedures and endocarditis prophylaxis in patients with prosthetic heart valves: results of a questionnaire to 220 patients. Scand J Infect Dis 1989; 21: 665-8.
28. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997; 277: 1794-801.
29. Littler WA, McGowan DA. Changes in recommendations about amoxycillin prophylaxis for prevention of endocarditis. Lancet 1997; 350. 1100.